A Database Cohort Study to Assess the Risk of Angioedema Among Patients with Heart Failure Initiating Angiotensin-Converting Enzyme Inhibitors in the USA

This publication has 18 references indexed in Scilit:

• Antihypertensive drug associated angioedema: effect modification by race/ethnicity
  Pharmacoepidemiology and Drug Safety, 2017
• Assessment of 105 Patients with Angiotensin Converting Enzyme-Inhibitor Induced Angioedema
  International Journal of Otolaryngology, 2017
• 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
  Circulation, 2016
• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
  European Heart Journal, 2016
• Epidemiology of Heart Failure
  Circulation Research, 2013
• Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System
  Archives of internal medicine (1960), 2012
• Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors
  Hypertension, 2008
• Incidence and Characteristics of Angioedema Associated With Enalapril
  Archives of internal medicine (1960), 2005
• Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*
  Clinical Pharmacology & Therapeutics, 1996
• Angiotensin converting enzyme inhibitor-associated angioedema: higher risk in blacks than whites
  Pharmacoepidemiology and Drug Safety, 1996